LY231514
Term · Oncology and biomedicine · MLC-T-ONC-005001
A drug used alone or with other drugs to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is also being studied in the treatment of other types of cancer. LY231514 stops cells from using folic acid to make DNA and may kill cancer cells. It is a type of antimetabolite and a type of antifolate. Also called Alimta, pemetrexed disodium, and Pemfexy.
| Identifier | MLC-T-ONC-005001 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | Alimta; pemetrexed disodium; Pemfexy |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005001",
"term": "LY231514",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat certain types of non-small cell lung cancer and malignant pleural mesothelioma. It is also being studied in the treatment of other types of cancer. LY231514 stops cells from using folic acid to make DNA and may kill cancer cells. It is a type of antimetabolite and a type of antifolate. Also called Alimta, pemetrexed disodium, and Pemfexy.",
"expansions": [
"Alimta",
"pemetrexed disodium",
"Pemfexy"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/ly231514/"
}
Record 10,435 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.